AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Israeli fintech Morning acquired for $150 million by Italy's TeamSystem
2
Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?
3
Can a tweet derail a $900 million cyber-tech deal?
4
SQream CEO Ami Gal steps down after 14 years
5
Israeli tech’s top 10 funding rounds of 2024: Wiz sets another record
More news

Nasdaq

20 stories about Nasdaq
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
נאסד"ק וול סטריט

Novartis-Backed Gamida Downgrades Nasdaq IPO Expectations to $50-$60 Million

18.10.18|Lilach Baumer
The Jerusalem-based biotech company filed for a $69 million initial public offering in September but disclosed no pricing terms
נאסד"ק וול סטריט

Biotech Company Gamida Cell Files for $69 Million Nasdaq IPO

30.09.18|Dror Reich
The Jerusalem-based company develops cellular and immune therapies. Its lead product is a universal bone marrow transplant solution
default image

Nasdaq-Listed Diabetes Monitoring Company Dario Raises $10.3 Million in Private Placement

16.09.18|CTech
Israel-headquartered Dario develops a diabetes monitoring device that lets users test and track their blood-glucose levels using a smartphone
נאסדק נאסד"ק ניו יורק בורסה בועה

Barclays Sees Potential Upside in Nice Stock Following Second-Quarter Reports

13.08.18|CTech
On Thursday, Israel-headquartered Nice reported GAAP revenues of $342 million, a 10% increase year-over-year, bolstered by a 28% year-over-year increase in cloud revenues
נאסד"ק וול סטריט

RedHill’s Clinical Trial Results Undermine Its Underwritten Offering

12.08.18|Dror Reich
The gastro treatment company announced a successful Crohn's disease treatment trial two weeks ago. While investors initially seemed hyped, successful trials from competitors brought RedHill’s stock down since
פאנל סולארי אנרגיה מתחדשת

SolarEdge Extends Patents Lawsuit Against Huawei

01.08.18|Amarelle Wenkert
The solar energy company has a pending lawsuit in Germany against the Chinese telecommunications company and a German distributor
תרופות כדורים

Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial

30.07.18|Lilach Baumer
The Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints
נאסדק נאסד"ק ניו יורק בורסה בועה

Surveillance Company Ability Looking to Raise Up to $50 Million in Shelf Offering

26.07.18|CTech
Earlier this month, the Tel Aviv-based company announced it has received a delisting determination from Nasdaq
שבתאי אדלרסברג

In Pivot, AudioCodes to Pay Out Dividends

25.07.18|Dror Reich
Revenue grew 12.3 percent to $43.5 million compared to the second quarter of last year
נאסדק נאסד"ק ניו יורק בורסה בועה

Wix.com Reports Higher Revenue and Improved Yearly Forecast

25.07.18|Asaf Shalev
The provider of website building tools also said it turned a profit in the second quarter excluding one-time items
מנכ"ל מדיגוס כריס רולנד

Medical Device Company Medigus Raises $10 Million in Public Offering

24.07.18|CTech
Medigus develops minimally invasive endosurgical tools and direct visualization technology
נאסד"ק וול סטריט

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer
The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market
נאסד"ק וול סטריט

Nasdaq Sends Notice of Delisting to Interception Company Ability

15.07.18|CTech
Last week, Tel Aviv-based Ability announced the SEC is considering disciplinary action against it in connection to a 2015 merger, and to business information filed by the company
רון בנצור

Sustained Drug Release Company UroGen Submits New Drug Application to FDA

12.07.18|Amir Rosenbaum
Kite Pharma founder Arie Belldegrun is the chairman of Israel-based UroGen, which focuses mainly on cancer treatment and urinary tract infections
נאסד"ק וול סטריט

Oral Insulin Capsule Developer Oramed Raises $18 Million in Direct Offering

10.07.18|CTech
Jerusalem-headquartered Oramed intends to use the recent proceeds for research and development and for clinical trials
נאסדק נאסד"ק ניו יורק בורסה בועה

SEC Considering Disciplinary Action Against Interception Company Ability

09.07.18|Dror Reich
Tel Aviv-based Ability has been under probe since February 2017 in regards to a 2015 merger, and to business information filed by the company
נאסד"ק וול סטריט

Cybersecurity Company Safe-T Group Submits Preliminary Prospectus for Nasdaq IPO

08.07.18|Lilach Baumer
The company is currently listed on the Tel Aviv Stock Exchange and on the OTCQB venture market
נאסד"ק וול סטריט

Fourth Time’s the Charm for Entera Bio IPO

01.07.18|Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Previous ArticlesMore Articles